Evidence map›Paper›PMID 39398828›Full record

ArticleCureus2024

Superior Vena Cava Syndrome Revealing Sarcoidosis a Decade Later: A Case Report.

Aziza Rhanim, Leila Achachi, Hajar Benataya, Mustapha El Ftouh, Laila Herrak

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Aziza RhanimDepartment of Pulmonology, Ibn Sina University Hospital Center, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, MAR.
Leila AchachiDepartment of Pulmonology, Ibn Sina University Hospital Center, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, MAR.
Hajar BenatayaDepartment of Pulmonology, Ibn Sina University Hospital Center, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, MAR.
Mustapha El FtouhDepartment of Pulmonology, Ibn Sina University Hospital Center, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, MAR.
Laila HerrakDepartment of Pulmonology, Ibn Sina University Hospital Center, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, MAR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sarcoidosis is a systemic disease of unknown origin, characterized by the formation of immune granulomas in various organs. The occurrence of superior vena cava syndrome (SVCS) remains very rare. We report the case of a 54-year-old patient treated for cervical lymph node tuberculosis in 2010. Three years later, she presented with SVCS of undetermined etiology. In 2023, mediastino-pulmonary sarcoidosis of type II was confirmed in her. The patient remained clinically stable under surveillance and did not receive any specific treatment for sarcoidosis. Superior vena cava syndrome is often associated with malignancy. Benign etiologies, particularly sarcoidosis, although rare, should be investigated.

Indexed as

granulomalymphadenopathysarcoidosissuperior vena cava syndromevessel

Identifiers

PMID39398828
PMCPMC11470227

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.